[Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma
Farmacia Hospitalaria · 2026-06
DOI: 10.1016/j.farma.2026.05.001 ↗Kurz gefasst
Fallbericht in der Zeitschrift Farmacia Hospitalaria, 2026-06. Verfasst von Carlota Rodríguez-Tenreiro Rodríguez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Gestión Clínica de Farmacia, Hospital Universitario Central de Asturias, Asturias, Spain. Electronic address: carlotarodrigueztenreiro@gmai…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Unidad de Gestión Clínica de Farmacia, Hospital Universitario Central de Asturias, Asturias, Spain. Electronic address: carlotarodrigueztenreiro@gmail.com.
- Unidad de Gestión Clínica de Farmacia, Hospital Universitario Central de Asturias, Asturias, Spain.
- Servicio de Oncología Médica, Hospital Universitario Central de Asturias, Asturias, Spain.
Zitieren
APA
Rodríguez-Tenreiro Rodríguez, C., Caso González, A., Muñoz Villasur, M., Roncero Sánchez, L., & Lozano Blázquez, A. (2026). [Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma. Farmacia Hospitalaria. https://doi.org/10.1016/j.farma.2026.05.001
Vancouver
Rodríguez-Tenreiro Rodríguez C, Caso González A, Muñoz Villasur M, Roncero Sánchez L, Lozano Blázquez A. [Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma. Farmacia Hospitalaria. 2026. doi:10.1016/j.farma.2026.05.001
BibTeX
@article{RodrguezTenreiroRodrguez2026,
author = {Rodríguez-Tenreiro Rodríguez, Carlota and Caso González, Alicia and Muñoz Villasur, Marina and Roncero Sánchez, Lucía and Lozano Blázquez, Ana},
title = {[Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma},
journal = {Farmacia Hospitalaria},
year = {2026},
doi = {10.1016/j.farma.2026.05.001}
}
EUVIMED